BioMimetic granted Canadian notice of patent allowance covering rhPDGF-BB platform technology formulations BioMimetic Therapeutics, Inc www.testosterone-p.com more info . announced today the Canadian Intellectual Property Workplace provides allowed patent program No. 2,583,823 titled Platelet Derived Development Aspect Compositions and Ways of Use Thereof . Once granted, it’ll be the 1st patent released to the business providing security in Canada and can expand its already solid patent portfolio, which also contains the U.S., the majority of the EU, Australia, New Zealand, South Mexico and Africa.
Today that the business offers partnered with Howard University Hospital announced, Department of Medical procedures to take part in a Community Wellness Project and Demonstration centered on diagnosing and dealing with the possibly life-threatening condition known as Peripheral Arterial Disease . Gwen Tillman, executive director, PAD Coalition at Vascular Disease Base was in attendance to greatly help reinforce the necessity for rapid medical diagnosis and treatment of PAD and take notice of the process.. BioMedix Vascular Solutions, Howard University Hospital to take part in Community Wellness Demonstration and Project BioMedix Vascular Solutions, Inc.